Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali

Name: Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali
Published: 2009
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID) · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

immunogenicity malaria plasmodium-falciparum safety vaccine

malaria, asexual blood stafe, plasmodium falciparum, immunogenicity, safety, vaccine, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali

Related documents